Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L. Telli, Andrea L. Richardson, James M. Ford et al.|Clinical Cancer Research|2016Cited by 1.2k
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerDaniel P. Silver, Judy E. Garber, Andrea L. Richardson et al.|Journal of Clinical Oncology|2010Cited by 983
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging AgentsNicolai J. Birkbak, Andrea L. Richardson, Zhigang C. Wang et al.|Cancer Discovery|2012Cited by 684
Pervasive chromosomal instability and karyotype order in tumour evolutionThomas B.K. Watkins, Mariam Jamal‐Hanjani, Emilia L. Lim et al.|Nature|2020Cited by 401
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophageAurélie Fluckiger, Vincent Cattoir, Romain Daillère et al.|Science|2020Cited by 382